**To the Editor**

First, the authors are thankful for the comments and for the opportunity to clarify points of our study published in Revista Brasileira de Terapia Intensiva.^([@r1])^ Our research line has involved investigating some functional assessment tools in different populations to identify functional behavior. In the study referred to above, we evaluated the use of the Perme Mobility Score in the intensive care unit during the postoperative period of liver transplantation.

We agree with the observation regarding the time spent on the transplant waiting list and its functional impact on these patients, as demonstrated by Casales et al.,^([@r2])^ and note that this variable is also a marker of mortality according to Galant et al.^([@r3])^ We are currently working on a future study in which the time spent on the transplant waiting list will be correlated with the functional assessment score to determine its possible impact and/or relationship. Regarding the issue of the nonexclusion of patients diagnosed with hepatopulmonary syndrome, we believe that during the posttransplant period, this variable (dyspnea) does not have an important impact on the functional assessment.

Regarding the use of the Perme score outside the intensive care unit, we agree with the observations made. In fact, our intention was to allow comparability by using the same tool, despite knowing that we could have used the Functional Independence Measure (FIM) or the Barthel index, as we have previously done when assessing critically ill patients after discharge from the ICU.^([@r4])^ An important point in this case would be to use a specific tool at each time point and to evaluate and compare their results through common points measured with the International Classification of Functioning (ICF).

We are thankful for the constructive observations, which, in our opinion, tend to raise the quality of future studies and foster scientific discussion.
